Lumenis Ltd. Introduces New FiberLase™ Drop-In Guide to Extend the Capabilities of Gynecologists and ENT Surgeons in Robotic Surgery

YOKNEAM, ISRAEL--(Marketwired - April 22, 2013) - Lumenis Ltd. announced today its new FiberLase Drop-In Guide, for use with the company’s AcuPulse™ 40 WaveGuide CO2 laser and its FiberLase family of CO2 fibers. The Drop-In Guide is able to provide Minimally Invasive Gynecologic and ENT Surgeons with an appropriate tool to successfully utilize Lumenis’ WaveGuide technology. With this introduction, Lumenis further extends their reach as the world’s largest medical laser company which develops, manufactures and distributes a broad range of medical lasers and sophisticated energy delivery equipment for surgical, aesthetic and ophthalmic applications.

The new Drop-In Guide extends physicians’ capabilities in robotic surgery by offering superior precision and better thermal control, improving the patient experience. Clinical applications for this product include laparoscopic procedures for endometriosis and adhesiolysis, as well as transoral head and neck surgeries.

The FiberLase Drop-In Guide features a red aiming beam that helps target delicate tissue leading to enhanced precision and a very small thermal footprint.(1,2) Additionally, the AcuPulse CO2 laser offers superior thermal control through three energy impact modes providing for a lower adjustable zone of thermal injury as compared to other energy devices. The FiberLase fiber is durable, can withstand tight bends and also offers the potential for less morbidity,(3,4) adhesion and scar formation as a result of minimal thermal damage.(3)

Additional benefits of the FiberLase CO2 Fiber and Drop-In Guide system include the ability to pass through a 5 mm trocar sleeve channel, and a fiber tip renewable during a surgical procedure.

“We are delighted to introduce the FiberLase Robotic Drop-In Guide to extend physicians’ capabilities in robotic surgery,” said Eran Kurman, Director Global Marketing - Surgical CO2 Lasers. “Lumenis’ Drop-In Guide and best in class fiber provide superior precision and thermal control in robotic surgery and also enhance robot utilization. It offers surgeons a valuable tool to improve outcomes for patients undergoing robotic laser surgery in a variety of areas, including minimally invasive gynecology and transoral head & neck procedures.”

About Lumenis
Lumenis, the world’s largest medical laser company, is a global developer, manufacturer and distributor of laser and light-based devices for surgical, aesthetic and ophthalmic applications, with more than 900 employees worldwide. Lumenis has 265 registered patents, over 260 FDA clearances, an install base of over 80,000 systems and presence in over 80 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability, delivering premium value and service to its customers. The name Lumenis is derived from a Latin word meaning “Light of Life”. Highlighting the light is the basis of our technologies used to enhance life. For more information about Lumenis and its products, please visit: www.lumenis.com.

Lumenis, its logo, AcuPulse and FiberLase are trademarks or registered trademarks of the Lumenis group of companies.

(1) Anderson Rox, Laser-Tissue Interaction; chapter in Cutaneous Laser Surgery: Goldman M, Fitzpatrick R; Mosby, 1994.
(2) Remacle Marc et. al.; Current State of Scanning Micromanipulator Applications With the Carbon Dioxide Laser; Annals of Otology, Rhinology & Laryngology, 117(4): 239-244.
(3) Meuleman Christel et. al.; Outcome after multidisciplinary CO2 laser laparoscopic excision of deep infiltrating colorectal endometriosis, Reproductive BioMedicine Online, Vol. 18, No. 2, 2009, 282-289.
(4) Albee Robert, in Surgical Management of Endometriosis, David Redwine, Publ. Martin Dunitz, 2004.
(5) Schipper Erica, Nezhat Camran; Video-assisted laparoscopy for the detection and diagnosis of endometriosis: safety, reliability and invasiveness; International Journal of Women’s Health 2012:4, 383 - 393.